echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Diagnostic Test > Complications and mortality for 30 days after artempus epilepsy temporal lobe removal

    Complications and mortality for 30 days after artempus epilepsy temporal lobe removal

    • Last Update: 2020-06-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The study showed that the hospital's capacity and epilepsy surgery were associated with complications during perioperative surgery, and the risk of postoperative complications in high-capacity hospitals was significantly lower than in low-capacity hospitals, so it was recommended that patients with epilepsy with comorbidities should be treated surgically in a specialist hospitalThe author concludes that temporal lobe excision can be effective in treating refractable temporal lobe epilepsy, but surgical intervention must weigh its complications and mortality, and patients with high risk factors should be treated individually- Excerpted from the article chapter: Kerezoudis P, et alJ Neurosurg2018 Apr; 128 (4): 1158-1164doi: 10.3171/2016.12.JNS162096Epub 2017 Jun 23."about 1 million people with drug-incurable epilepsy in the United StatesSurgical treatment is considered once it has been diagnosed as a refractive epilepsy drug that has failed two anti-epileptic medicationsTemporal lobe epilepsy (TLE) is one of the most common types of refractive epilepsy; there is evidence that temporal loystomy improves its symptoms, but most patients do not have surgery at the time of treatment and lack large sample data on tatters of complications after TLERetrospective analysis of patients with temporal excision, including demographic characteristics, hospitalization and surgical information, and 30 days after surgery, was published in the April 2018 issue of J.JNeurourg, in the April 2018 issue of J.JNeuros, according to the American College of Surgeons' National Surgical Quality Improvement Program (ACS-NSQIP) databasestudy included 216 patients with TLE who met the criteria from 2006 to 2014, of which 177 were routinely prefrontal lobe excision and 39 were selective amygdala hippocampusThe average age of the patients was 38 years, with 99 cases of menHospitalization and surgery information: 140-534 minutes of surgery, an average of 241.5 minutes, hospitalization time of 1-22 days, an average of 3 days, 43 cases (19.9%) of patients stayed in hospital for more than 5 days Complications and mortality: 1.39% death rate 30 days after surgery, 14 cases (6.48%) serious complications; Minor complications included deep vein thrombosis and urinary tract infections of 0.46% and 0.93%, respectively After 2011, 155 patients were admitted to hospital, and the percentage of readmission and 10.3% were admitted again within 30 days of surgery, respectively, and 7 (3.24%) were re-operated within 30 days of surgery associated with poor prognosis with age, especially patients over 55 years of age and treatment received outside the hospital, patients with men are more likely to have postoperative complications than female patients, and the attending physician and resident surgery are more likely than 1 physician to perform surgery, which can significantly reduce the patient's hospital stay and the possibility of transfer to out-of-hospital treatment the study showed that the hospital's capacity and epilepsy surgery were associated with complications during perioperative surgery, and the risk of postoperative complications in high-capacity hospitals was significantly lower than in low-capacity hospitals, so it was recommended that patients with epilepsy with comorbidities should go to a specialist hospital for surgical treatment The author concludes that temporal lobe excision can be effective in treating refractable temporal lobe epilepsy, but surgical intervention must weigh its complications and mortality, and patients with high risk factors should be treated individually.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.